Budapest, Hungary

Agnes Udvardi


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Agnes Udvardi: Innovator in Pharmaceutical Technology

Introduction

Agnes Udvardi is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of stabilized, prostaglandin-containing tablets. Her innovative work has the potential to enhance local therapeutic applications.

Latest Patents

Udvardi holds a patent for "Stabilized, prostaglandin-containing tablets with controlled rate of solubility." This invention relates to tablets designed for local use, which contain a specific range of natural or synthetic prostaglandins, buffers, and other components. The tablets are formulated to ensure a controlled rate of solubility, which is crucial for their effectiveness. The patent details the composition, including 0.2 to 20% by weight of prostaglandins, 0.4 to 40% by weight of a non-toxic buffer, and other ingredients, all prepared under specific pressure conditions.

Career Highlights

Agnes Udvardi is associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company. Her work at this institution has allowed her to focus on innovative drug formulations that address specific medical needs. With her expertise, she has contributed to advancements in the pharmaceutical industry.

Collaborations

Udvardi has collaborated with notable colleagues, including Agoston David and Tibor Horvath. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Agnes Udvardi's contributions to pharmaceutical technology exemplify the impact of innovation in healthcare. Her patented work on stabilized prostaglandin tablets showcases her commitment to improving therapeutic options for patients. Through her career and collaborations, she continues to influence the pharmaceutical landscape positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…